evodiamine has been researched along with Colorectal Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, X; Vong, CT; Wang, Y; Xiao, J; Zhao, J; Zheng, X; Zhong, Z | 1 |
| Chen, DL; Chen, Y; Guo, XX; Jiang, R; Li, J; Li, XP; Lv, XT; Lv, YW; Ran, JH; Tian, K; Yuan, DZ; Zhou, P | 1 |
| Cai, G; Cai, J; Gao, R; Ji, Q; Li, C; Li, Q; Song, D; Sui, H; Teng, P; Wang, Y; Zhou, L | 1 |
| Chen, CH; Chen, YC; Chien, CC; Ko, CH; Shen, SC; Wu, MS; Yang, LL | 1 |
| Chen, DL; Feng, ZQ; Li, J; Liao, K; Luo, N; Shi, QQ; Zhao, LC | 1 |
| Chen, ZS; Deng, WL; Fu, XL; Huang, JP; Ji, Q; Li, Q; Liu, X; Sui, H; Wen, HT; Zhang, YL; Zhou, LH; Zhu, HR | 1 |
| Chen, AQ; Liu, B; Yang, ZG | 1 |
7 other study(ies) available for evodiamine and Colorectal Neoplasms
| Article | Year |
|---|---|
Combined effects of berberine and evodiamine on colorectal cancer cells and cardiomyocytes in vitro.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Berberine; Caco-2 Cells; Cardiotoxicity; Colon; Colorectal Neoplasms; Drug Screening Assays, Antitumor; Drug Synergism; Drugs, Chinese Herbal; Epithelial Cells; HT29 Cells; Humans; Intestinal Mucosa; Myocytes, Cardiac; Quinazolines; Rats | 2020 |
Evodiamine inhibits migration and invasion by Sirt1-mediated post-translational modulations in colorectal cancer.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; NF-kappa B; Phosphorylation; Protein Processing, Post-Translational; Quinazolines; Sirtuin 1; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Male; Mice; Mice, Inbred ICR; Molecular Structure; Neoplasms, Experimental; Quinazolines; Structure-Activity Relationship; Tumor Cells, Cultured | 2019 |
Activation of JNK contributes to evodiamine-induced apoptosis and G2/M arrest in human colorectal carcinoma cells: a structure-activity study of evodiamine.
Topics: Alkylation; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; HT29 Cells; Humans; M Phase Cell Cycle Checkpoints; MAP Kinase Signaling System; Mice; NIH 3T3 Cells; Quinazolines; Structure-Activity Relationship | 2014 |
Evodiamine Induces Apoptosis and Inhibits Migration of HCT-116 Human Colorectal Cancer Cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Janus Kinase 2; Plant Extracts; Protein Kinase Inhibitors; Quinazolines; Signal Transduction | 2015 |
Evodiamine Suppresses ABCG2 Mediated Drug Resistance by Inhibiting p50/p65 NF-κB Pathway in Colorectal Cancer.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Down-Regulation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Mice; Neoplasm Proteins; NF-kappa B; Quinazolines; Signal Transduction; Xenograft Model Antitumor Assays | 2016 |
Antiproliferation and apoptosis induced by evodiamine in human colorectal carcinoma cells (COLO-205).
Topics: Anticarcinogenic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma; Caspase 3; Cell Cycle; Cell Proliferation; Colorectal Neoplasms; Evodia; G2 Phase; Humans; Membrane Potentials; Mitochondria; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; Quinazolines; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2009 |